[ESPR] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
04-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -11.15%
YoY- -27.20%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -28,956 -17,402 -14,035 -14,585 -13,122 -12,801 -12,395 75.60%
Tax 423 488 494 457 287 378 337 16.28%
NP -28,956 -17,402 -14,035 -14,585 -13,122 -12,801 -12,395 75.60%
Tax Rate - - - - - - - -
Total Cost 28,956 17,402 14,035 14,585 13,122 12,801 12,395 75.60%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -1.28 -0.77 -0.62 -0.65 -0.58 -0.57 -0.55 75.16%
EPS Diluted -1.28 -0.77 -0.62 -0.65 -0.58 -0.57 -0.55 75.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.